National Research (NASDAQ:NRC) Stock Price Crosses Above 200 Day Moving Average – What’s Next?

National Research Corporation (NASDAQ:NRC)’s stock price crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $16.61 and traded as high as $19.31. National Research shares last traded at $18.74, with a volume of 132,991 shares traded.

Analysts Set New Price Targets

Separately, Weiss Ratings downgraded shares of National Research from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Friday, March 6th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company currently has a consensus rating of “Sell”.

National Research Stock Up 2.9%

The firm’s 50 day moving average price is $16.39 and its two-hundred day moving average price is $16.61. The company has a market cap of $426.34 million, a P/E ratio of 48.05 and a beta of 0.31. The company has a debt-to-equity ratio of 5.36, a quick ratio of 0.55 and a current ratio of 0.55.

National Research (NASDAQ:NRC) last released its quarterly earnings data on Tuesday, April 28th. The company reported $0.21 earnings per share for the quarter. The company had revenue of $34.80 million during the quarter. National Research had a net margin of 6.52% and a return on equity of 117.08%.

National Research Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 10th. Stockholders of record on Friday, June 26th will be paid a $0.16 dividend. The ex-dividend date is Friday, June 26th. This represents a $0.64 annualized dividend and a dividend yield of 3.4%. National Research’s payout ratio is currently 164.10%.

Institutional Trading of National Research

Several hedge funds have recently modified their holdings of the stock. Bank of New York Mellon Corp increased its stake in shares of National Research by 4.0% in the 1st quarter. Bank of New York Mellon Corp now owns 250,707 shares of the company’s stock valued at $4,257,000 after acquiring an additional 9,730 shares in the last quarter. Fifth Third Bancorp bought a new stake in shares of National Research in the 1st quarter valued at $1,531,000. Hsbc Holdings PLC bought a new stake in shares of National Research in the 1st quarter valued at $180,000. DGS Capital Management LLC bought a new stake in shares of National Research in the 4th quarter valued at $274,000. Finally, Invesco Ltd. increased its stake in shares of National Research by 14.9% in the 4th quarter. Invesco Ltd. now owns 21,598 shares of the company’s stock valued at $405,000 after acquiring an additional 2,799 shares in the last quarter. Institutional investors own 47.26% of the company’s stock.

National Research Company Profile

National Research Corp (NASDAQ: NRC), also known as NRC Health, is a healthcare analytics and performance improvement company specializing in patient and employee experience measurement. The company’s cloud-based platform enables healthcare providers to collect real-time feedback through patient satisfaction surveys, post-discharge outreach, and employee engagement tools. NRC Health integrates clinical, operational and financial data to deliver actionable insights that support quality improvement initiatives and value-based care programs.

Since its founding in the early 1990s and headquartered in Lincoln, Nebraska, National Research has expanded beyond its regional roots to serve more than 1,600 hospitals and 12,000 care sites across the United States and Canada.